Appili Therapeutics Pink Sheet Forward View - Simple Exponential Smoothing
| APLIF Stock | USD 0.01 0 11.76% |
Appili Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Appili Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 1st of February 2026, the relative strength index (RSI) of Appili Therapeutics' share price is approaching 43. This suggests that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Appili Therapeutics, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
Using Appili Therapeutics hype-based prediction, you can estimate the value of Appili Therapeutics from the perspective of Appili Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Appili Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0009 and the sum of the absolute errors of 0.06. Appili Therapeutics after-hype prediction price | USD 0.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Appili |
Appili Therapeutics Additional Predictive Modules
Most predictive techniques to examine Appili price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Appili using various technical indicators. When you analyze Appili charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Appili Therapeutics Simple Exponential Smoothing Price Forecast For the 2nd of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Appili Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0009, mean absolute percentage error of 0.00000156, and the sum of the absolute errors of 0.06.Please note that although there have been many attempts to predict Appili Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Appili Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Appili Therapeutics Pink Sheet Forecast Pattern
| Backtest Appili Therapeutics | Appili Therapeutics Price Prediction | Buy or Sell Advice |
Appili Therapeutics Forecasted Value
In the context of forecasting Appili Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Appili Therapeutics' downside and upside margins for the forecasting period are 0.0001 and 8.87, respectively. We have considered Appili Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Appili Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Appili Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 102.9015 |
| Bias | Arithmetic mean of the errors | 2.0E-4 |
| MAD | Mean absolute deviation | 9.0E-4 |
| MAPE | Mean absolute percentage error | 0.0573 |
| SAE | Sum of the absolute errors | 0.0555 |
Predictive Modules for Appili Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Appili Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Appili Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Appili Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Appili Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Appili Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Appili Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Appili Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Appili Therapeutics' historical news coverage. Appili Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 8.95, respectively. We have considered Appili Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Appili Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Appili Therapeutics is based on 3 months time horizon.
Appili Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Appili Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Appili Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Appili Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 8.86 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.02 | 33.33 |
|
Appili Therapeutics Hype Timeline
Appili Therapeutics is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Appili is forecasted to increase in value after the next headline, with the price projected to jump to 0.02 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 33.33%, whereas the daily expected return is presently at 0.09%. The volatility of related hype on Appili Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.02. Appili Therapeutics has accumulated 4.88 M in total debt with debt to equity ratio (D/E) of 0.17, which may suggest the company is not taking enough advantage from borrowing. Appili Therapeutics has a current ratio of 1.95, which is within standard range for the sector. Debt can assist Appili Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Appili Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Appili Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Appili to invest in growth at high rates of return. When we think about Appili Therapeutics' use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Appili Therapeutics to cross-verify your projections.Appili Therapeutics Related Hype Analysis
Having access to credible news sources related to Appili Therapeutics' direct competition is more important than ever and may enhance your ability to predict Appili Therapeutics' future price movements. Getting to know how Appili Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Appili Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AGNPF | Algernon Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.06) | 14.10 | (13.67) | 31.25 | |
| RNUGF | ReNeuron Group Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ADXS | Ayala Pharmaceuticals | 0.00 | 0 per month | 23.17 | 0.23 | 122.19 | (53.64) | 734.55 | |
| IBOGF | Universal Ibogaine | 0.00 | 0 per month | 18.41 | 0.12 | 38.00 | (29.69) | 105.56 | |
| NMLSF | Nova Mentis Life | 0.00 | 0 per month | 5.98 | 0.09 | 16.00 | (13.81) | 66.40 | |
| RGBP | Regen BioPharma | 0.00 | 0 per month | 0.00 | (0.06) | 20.00 | (17.00) | 63.57 | |
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AAGH | America Great Health | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 50.00 | |
| IBXXF | Imagion Biosystems Limited | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 66.67 | |
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Appili Therapeutics
For every potential investor in Appili, whether a beginner or expert, Appili Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Appili Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Appili. Basic forecasting techniques help filter out the noise by identifying Appili Therapeutics' price trends.Appili Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Appili Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Appili Therapeutics could also be used in its relative valuation, which is a method of valuing Appili Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Appili Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Appili Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Appili Therapeutics shares will generate the highest return on investment. By undertsting and applying Appili Therapeutics pink sheet market strength indicators, traders can identify Appili Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 0.015 | |||
| Day Typical Price | 0.015 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 43.47 |
Appili Therapeutics Risk Indicators
The analysis of Appili Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Appili Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting appili pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.33 | |||
| Semi Deviation | 7.06 | |||
| Standard Deviation | 9.47 | |||
| Variance | 89.66 | |||
| Downside Variance | 203.62 | |||
| Semi Variance | 49.86 | |||
| Expected Short fall | (14.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Appili Therapeutics
The number of cover stories for Appili Therapeutics depends on current market conditions and Appili Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Appili Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Appili Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Appili Pink Sheet
Appili Therapeutics financial ratios help investors to determine whether Appili Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.